Cochlear™ Baha® Start

Baha Start may give you or your child the opportunity to experience sound and help provide the hearing they need to develop and grow.


Baha® Start is our non-surgical solution designed to deliver clear, rich and natural sound1 for those who want to try, or are not yet ready for an implantable solution.

Baha Start can allow your child to access sound as early as possible and give them the best importunity to learn and communicate on par with hearing peers.2-4

It also provide adults with an option to trial the benefits of bone conduction hearing before making a decision on moving forward with an implant.


Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

For a full list of Cochlear’s trademarks, please visit our Terms of Use page.

In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.

In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.

In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.

For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.

Any testimonial featured on this website is intended for an Australian audience only.


  1. Hoffman J. Subjective evaluation of clear rich and natural sound. Cochlear Bone Anchored Solutions AB, Sweden. 2020; D1788013.
  2. Yoshinaga-Itano C. Early Intervention after universal neo-natal hearing screening: impact on outcomes. Dev Disabil Res Rev. 2003;9(4):252-66.
  3. Judith E. Cho Lieu. Speech-Language and Educational Consequences of Unilateral Hearing Loss in Children. Arch Otolaryngol Head Neck Surg. 2004;130(5):524-30.
  4. Impact of Unilateral Conductive Hearing Loss Due to Aural Atresia on Academic Performance in Children. Laryngoscope. 2013;123:2270–2275.